Fight Parkinson’s Launches 2025 Seed Grant Program to Fund Research Innovation
Seed Funding Grants are available for both clinical and basic science research, with each category offering a grant of $30,000. These grants underpin Fight Parkinson’s ongoing commitment to raise funds to support research focused on the prevention, improvement of life, and eventual cure for Parkinson’s Disease, Progressive Supranuclear Palsy (PSP), Corticobasal Syndrome (CBS), and Multiple […]
A Groundbreaking Breakthrough: The Parkinson’s Biomarker
This groundbreaking development promises to over time revolutionise the diagnosis and treatment of Parkinson’s disease, marking a significant milestone. Professor David Finkelstein, head of the Parkinson’s Laboratory at The Florey Institute, Director on the Fight Parkinson’s board and the chair of the Fight Parkinson’s research committee, has shared this important advance at a Fight Parkinson’s […]
Parkinson’s Prevalence
Estimates of people living with Parkinson’s has more than doubled Based on ABS statistics and scientific peer reviewed prevalence data, there are an estimated 57,000 Victorians living with Parkinson’s and 219,000 nationally. This is more than double the previous figures of 27,000 Victorians and 100,000 Australian reported in 2015. Since then, from more recent evidence-based […]
International Women’s Day
The incidence of Parkinson’s is lower in women than men, however there are many women living with Parkinson’s and their experience is often very different to that of men. Some studies have indicated women experience tremor and painful early morning muscle contractions than men. Others have found women are more likely to have depression and […]
Fight Parkinson’s-backed research shows improved outcomes using wearable device
Fight Parkinson’s has welcomed publication of a study adding to the body of evidence showing the advantages of using a wearable, continuous objective measurement system to monitor and manage motor symptoms affecting people with Parkinson’s.
Deloitte Access Economics report
Key findings of the Deloitte Access Economics report include: Parkinson’s costs the Australian community almost $10 billion each year. This figure has almost doubled since 2005 Since 2005, there’s been an increase of 103 percent in direct financial costs of Parkinson’s ($1.1 billion) and an increase of 42 percent ($8.9 billion) in the burden of […]
Fact sheet – Parkinson’s research in Australia
Research plays a vital role in improving the lives of people with Parkinson’s and moving us closer to a cure. This resource offers an overview of Parkinson’s research in Australia, including key areas of focus and how you can get involved. This fact sheet covers: Current areas of research Clinical trials and participation The role […]